ICCC Stock Analysis: Buy, Sell, or Hold?

ICCC - Immucell Corp

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$10.29
-0.71 (-6.45%) ▼
5d: +4.04%
30d: +5.11%
90d: +62.05%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026

Get Alerted When ICCC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ICCC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ICCC is currently trading at $10.29, which is considered extended relative to its 30-day fair value range of $9.52 to $10.25.

Technical Outlook: Technically, ICCC is in a strong uptrend. Immediate support is located at $9.29, while resistance sits at $10.75. Short-term momentum is weak, with the stock down 6.5% recently.

Market Sentiment: ICCC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.00 (+36.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $9.52 - $10.25
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 57.9%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.5%)
  • BULLISH: Trading 36.1% below Wall St target ($14.00)

Trading Range Analysis

30-Day Trading Range $9.52 - $10.25
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $9.29
Resistance Level $10.75
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Wall Street Target $14.00 (+36.1%)
Revenue Growth (YoY) 28.4%
Earnings Growth (YoY) 31.3%
Profit Margin -1.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 03, 2026 6:54 PM ET
Data refreshes hourly during market hours. Next update: 7:54 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ICCC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$88 63 BUY
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1041 62 BUY
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 63 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$106 64 BUY
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$57 51 HOLD

More Analysis for ICCC

ICCC Technical Chart ICCC Price Prediction ICCC Earnings Date ICCC Investment Advisor ICCC Fair Price Analyzer ICCC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals